Segment, Customer and Geographical Reporting (Tables)

12 Months Ended

Sep. 30, 2016

The Company’s segment information is summarized below:

Results of Operations for the Fiscal Year Ended September 30,
2016
	Optics			Contract Research			Biomedical		Total
Revenue	$	23,686,000		$	19,756,000		$	-	$	43,442,000
Gross profit		8,010,000			7,593,000			-		15,603,000
GM %		34	%		38	%		-		36	%
SG&A		6,239,000			6,619,000			2,070,000		14,928,000
Gain on sale of assets		(4,000)			-			-		(4,000)
Operating income (loss)		1,775,000			974,000			(2,070,000)		679,000

Depreciation and amortization		949,000			249,000			69,000		1,267,000
Capital expenditures		1,503,000			432,000			109,000		2,044,000

Intangibles, net		517,000			230,000			320,000		1,067,000
Goodwill		959,000			4,939,000			-		5,898,000
Total assets	$	17,397,000		$	8,325,000		$	647,000	$	26,369,000

Results of Operations for the Fiscal Year Ended September 30,
2015
	Optics			Contract Research			Biomedical		Total
Revenue	$	21,783,000		$	18,753,000		$	-	$	40,536,000
Gross profit		6,818,000			8,176,000			-		14,994,000
GM %		31	%		44	%		-		37	%
SG&A		6,020,000			7,301,000			1,717,000		15,038,000
Gain on sale of assets		(178,000)			-			-		(178,000)
Operating income (loss)		976,000			875,000			(1,717,000)		134,000

Depreciation and amortization		839,000			296,000			61,000		1,196,000
Capital expenditures		1,173,000			91,000			119,000		1,383,000

Intangibles, net		678,000			264,000			283,000		1,225,000
Goodwill		1,192,000			4,939,000			-		6,131,000
Total assets	$	15,984,000		$	7,692,000		$	828,000	$	24,504,000

Revenue by geographic location in total and as a percentage of total revenue, for the years ended September 30, 2016 and 2015 are as follows: